Literature DB >> 15111801

Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects.

Troels T Andreassen1, Vittorio Cacciafesta.   

Abstract

This study investigates the effects of intermittent parathyroid hormone (PTH(1-34)) treatment on bone regeneration and mechanical strength of critically sized rat calvarial bone defects covered with expanded membranes. A full-thickness bone defect (diameter 5 mm) was trephined in the central part of the parietal bones in 20-month-old female Wistar rats. The bone defects were covered with an exocranial and an endocranial expanded polytetrafluoroethylene membrane. The animals were killed 35 days after operation. 60 microg PTH(1-34)/kg was administered daily during the healing period, and control animals with calvarial bone defects were given vehicle. Mechanical testing was performed by a punch out testing procedure by placing a steel punch (diameter 3.5 mm) in the center of the healed defect. After mechanical testing, the newly formed tissue inside the defect was removed and the dry weight and ash weight were measured. PTH(1-34) increased dry weight by 48%, ash weight by 51%, and ash concentration by 26%. PTH(1-34) also augmented the mechanical strength of the new bone formed inside the defect by increasing ultimate stiffness by 87%. No differences in body weight were found between the vehicle-injected and the PTH-treated animals during the experiment. The experiment demonstrates that intermittent PTH(1-34) treatment increases bone deposition and enhances mechanical strength of healing rat calvarial defects covered with expanded polytetrafluoroethylene membranes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111801     DOI: 10.1097/00001665-200405000-00014

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  11 in total

Review 1.  Endogenous tissue engineering: PTH therapy for skeletal repair.

Authors:  Masahiko Takahata; Hani A Awad; Regis J O'Keefe; Susan V Bukata; Edward M Schwarz
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

2.  Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.

Authors:  K M Kim; W Park; S Y Oh; H-J Kim; W Nam; S-K Lim; Y Rhee; I H Cha
Journal:  Osteoporos Int       Date:  2014-02-20       Impact factor: 4.507

Review 3.  Parathyroid hormone applications in the craniofacial skeleton.

Authors:  H L Chan; L K McCauley
Journal:  J Dent Res       Date:  2012-10-15       Impact factor: 6.116

4.  Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse.

Authors:  U T Iwaniec; C H Trevisiol; G F Maddalozzo; C J Rosen; R T Turner
Journal:  Bone       Date:  2008-01-12       Impact factor: 4.398

5.  Effect of intermittent PTH (1-34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model.

Authors:  Z Qiu; L Wei; J Liu; K R Sochacki; X Liu; C Bishop; M Ebraheim; H Yang
Journal:  Osteoporos Int       Date:  2013-06-12       Impact factor: 4.507

6.  Impact of Release Kinetics on Efficacy of Locally Delivered Parathyroid Hormone for Bone Regeneration Applications.

Authors:  Samantha J Wojda; Ian A Marozas; Kristi S Anseth; Michael J Yaszemski; Seth W Donahue
Journal:  Tissue Eng Part A       Date:  2020-09-10       Impact factor: 3.845

7.  Intermittent administration of parathyroid hormone improves the repairing process of rat calvaria defects: A histomorphometric and radiodensitometric study.

Authors:  Eduardo-de-Paula Silva; Daniel-Fernando-Pereira Vasconcelos; Marcelo-Rocha Marques; Marco-Antônio Dias da Silva; Flávio-Ricardo Manzi; Silvana-Pereira Barros
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01

8.  Phospholipase C signaling activated by parathyroid hormone mediates the rapid osteoclastogenesis in the fracture healing of orchiectomized mice.

Authors:  Wei Li; Liang Yuan; Guojun Tong; Youhua He; Yue Meng; Song Hao; Jianting Chen; Jun Guo; Richard Bringhurst; Dehong Yang
Journal:  BMC Musculoskelet Disord       Date:  2018-08-29       Impact factor: 2.362

Review 9.  The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease.

Authors:  Takahiro Makino; Hiroyuki Tsukazaki; Yuichiro Ukon; Daisuke Tateiwa; Hideki Yoshikawa; Takashi Kaito
Journal:  Int J Mol Sci       Date:  2018-08-17       Impact factor: 5.923

10.  High dose teriparatide (rPTH1-34) therapy increases callus volume and enhances radiographic healing at 8-weeks in a massive canine femoral allograft model.

Authors:  Kohei Nishitani; Zachary Mietus; Christopher A Beck; Hiromu Ito; Shuichi Matsuda; Hani A Awad; Nicole Ehrhart; Edward M Schwarz
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.